The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
Simon Cowell admitted he was "so embarrassed" after his shirt burst open during an X Factor audition.
Following the promise of further powers for Scotland, David Cameron is now talking about a new deal for the other home nations.
The Suitsy: Man creates business suit onesie